Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Using microarray analysis, we have detected downregulation of several components of the cGMP signaling pathway during replicative senescence of primary human diploid fibroblasts (HDFs). Therefore, the effect of pharmacological inhibition of cGMP synthesis was analyzed in HDFs. Treatment with 6-anilino-5,8-quinolinequinone (LY83583, referred to as LY hereafter), a previously described inhibitor of guanylate cyclase, induced cellular senescence. Microarray analysis revealed that LY treatment induced the Cdk inhibitor p21(WAF1/SDI/CIP1). In colorectal cancer cells, transcription of p21 was induced by LY in a p53-independent manner. Furthermore, p21, but not p53, was required for inhibition of proliferation by LY. The lack of p53 involvement suggests that LY does not induce DNA damage. Growth inhibition was also observed in malignant melanoma and breast cancer cell lines. Functional inactivation of the retinoblastoma tumor-suppressor protein, an effector of p21-mediated cell-cycle inhibition, converted LY-induced growth arrest to apoptosis. These results suggest that LY, or derivatives, may be useful therapeutic agents for the treatment of tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“This result was unexpected, since p16INK4A is commonly induced in scenarios that lead to premature senescence — for example, ectopic expression of an activated ras gene (27) or suboptimal cell-culture conditions (10).”
BackgroundRequirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803 · cited 1×
“(33) showed a complete block of proliferation after addition of LY (Figure 4b).”
Backgroundp53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459 · cited 1×
“Supporting this notion on the organismal level, mice that have been engineered to display elevated p53 activity show a decreased rate of tumor formation and premature aging (6).”
BackgroundCloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351
Hayflick, his limit, and cellular ageing
Shay, J. W., & Wright, W. E. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036093 · Cited by 764
Microarray analysis of replicative senescence
Shelton, D. N., Chang, E., Whittier, P. S., Choi, D., & Funk, W. D. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80420-5 · Cited by 764
Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
Waldman, T., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1996) · Nature · doi:10.1038/381713a0 · Cited by 728
Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions
Ramirez, R. D., Morales, C. P., Herbert, B.-S., Rohde, J. M., Passons, C., Shay, J. W., & Wright, W. E. (2001) · Genes & Development · doi:10.1101/gad.859201 · Cited by 444 · cited 2×
“This result was unexpected, since p16INK4A is commonly induced in scenarios that lead to premature senescence — for example, ectopic expression of an activated ras gene (27) or suboptimal cell-culture conditions (10).”
Background
Research works printed but not linked: 40
- 10.1016/S1535-6108(02)00024-7 · DOI · Paper page
- 10.1016/0014-4827(65)90211-9 · DOI · Paper page
- 10.1016/S0955-0674(00)00278-7 · DOI · Paper page
- Campisi, 2001, Trends Cell Biol, 11, 27, 10.1016/S0962-8924(01)02151-1 · DOI · Paper page
- 10.1083/jcb.149.5.1117 · DOI · Paper page
- 10.1126/science.277.5327.831 · DOI · Paper page
- Cristofalo, 1998, Gene Expr, 8, 43
- 10.1101/gad.8.21.2540 · DOI · Paper page
- Chang, 1999, Oncogene, 26, 4808, 10.1038/sj.onc.1203078 · DOI · Paper page
- 10.1073/pnas.082005599 · DOI · Paper page
- 10.1093/nar/29.10.2003 · DOI · Paper page
- 10.1073/pnas.92.20.9363 · DOI · Paper page
- 10.1016/0092-8674(93)90500-P · DOI · Paper page
- 10.1016/0531-5565(95)02013-6 · DOI
- 10.1126/science.287.5462.2486 · DOI · Paper page
- 10.1016/0014-5793(92)80594-7 · DOI · Paper page
- Giuili, 1993, Hum Genet, 91, 257, 10.1007/BF00218267 · DOI
- Hofmann, 2000, J Cell Sci, 113, 1671
- Fleisch, 1984, J Pharmacol Exp Ther, 229, 681
- 10.1016/S0092-8674(00)81684-0 · DOI · Paper page
- 10.1016/0092-8674(93)90499-G · DOI · Paper page
- Harper, 1995, Cell, 6, 387
- 10.1038/sj.onc.1202575 · DOI · Paper page
- 10.1016/0092-8674(95)90385-2 · DOI · Paper page
- Myohanen, 1998, Cancer Res, 58, 591
- 10.1073/pnas.91.22.10412 · DOI
- 10.1016/0092-8674(88)90559-4 · DOI · Paper page
- 10.1073/pnas.87.7.2775 · DOI · Paper page
- 10.1038/sj.onc.1204958 · DOI
- Hollstein, 1999, Mutat Res, 431, 7, 10.1016/S0027-5107(99)00162-1 · DOI · Paper page
- Schmidt, 1985, J Pharmacol Exp Ther, 232, 764
- Mulsch, 1988, J Pharmacol Exp Ther, 247, 283
- Cherry, 1990, Am J Physiology, 259, 1056
- 10.1093/toxsci/63.2.214 · DOI · Paper page
- 10.1126/science.278.5340.1064 · DOI · Paper page
- 10.1046/j.1365-2354.2001.00272.x · DOI · Paper page
- Patridge, 2001, J Natl Cancer Inst Monogr, 30, 135, 10.1093/oxfordjournals.jncimonographs.a003451 · DOI · Paper page
- Felix, 1998, Biochim Biophys Acta, 1400, 233, 10.1016/S0167-4781(98)00139-0 · DOI · Paper page
- 10.1080/028418602760169361 · DOI · Paper page
- Untergasser, 2002, Cancer Res, 62, 6255
Cited by
Tarasov, V., Jung, P., Verdoodt, B., Lodygin, D., Epanchintsev, A., Menssen, A., Meister, G., & Hermeking, H. (2007) · Cell Cycle · doi:10.4161/cc.6.13.4436 · Cited by 923
Self-citationSu, M., Xiao, Y., Ma, J., Tang, Y., Tian, B., Zhang, Y., Li, X., Wu, Z., Yang, D., Zhou, Y., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1002-6 · Cited by 457
Hermeking, H. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1230 · Cited by 437
Self-citationGentles, A. J. (2010) · JAMA · doi:10.1001/jama.2010.1862 · Cited by 395
Functional Epigenomics Identifies Genes Frequently Silenced in Prostate Cancer
Lodygin, D., Epanchintsev, A., Menssen, A., Diebold, J., & Hermeking, H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4407 · Cited by 286
Self-citation
Metadata
- Authors
- Lodygin, D., Menssen, A., & Hermeking, H.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-12-01
- Volume
- 110
- Issue
- 11
- Pages
- 1717-1727
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1973879142
- Cited by
- 74
- References
- 8
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner. https://app.cochat.ai/papers/10.1172/jci16588
- The paper
- Lodygin, D., Menssen, A., & Hermeking, H. (2002). Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner. Journal of Clinical Investigation. https://doi.org/10.1172/jci16588
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.